Suppliers / Công ty Cổ Phần Dược Phẩm Reliv

Công ty Cổ Phần Dược Phẩm Reliv

54 employees Updated 9 July 2026

Công ty Cổ Phần Dược Phẩm Reliv is an API manufacturer. It appears in 82 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam) and NPRA (MY).

0
active US DMFs
0
valid CEPs
0
registered plants
82
filings across 2 regulators

What they file, and where

Molecule Regulators Docs
Ciprofloxacin DAV (Vietnam) 1
Erlotinib DAV (Vietnam) 1
Sorafenib DAV (Vietnam) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 81 None
NPRA (MY) 1 None

Comparing suppliers?

Choose your molecules and target markets. Công ty Cổ Phần Dược Phẩm Reliv comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability